GT Biopharma Inc (GTBP)

[LT777]

"Oxis' Technology is Lightning in a Bottle"

NEW YORK, NY / ACCESSWIRE / July 27, 2015 / Oxis International, Inc. (OXIS) (OXI.PA) through its wholly owned subsidiary Oxis Biotech, Inc., today published a new blog post on The Chairman's Blog, written by the Company's Chairman and Chief Executive Officer, Anthony Cataldo. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his inaugural blog post, Oxis Chairman and Chief Executive Officer Anthony Cataldo, discusses the unmet medical need for effective treatment options for triple negative breast cancer (TNBC) and multiple myeloma. He offers a look into his past experience in leading an evolving biotech company to commercialize a product that has changed the lives of cancer patients and shares how he is advancing upon a similar opportunity with Oxis. Read the full blog post from Mr. Cataldo on TheChairmansBlog.com (http://www.thechairmansblog.com/oxis-international/anthony-cataldo/oxis-technology-is-lightning-in-a-b

From Yahoo Finance 8:40 a.m. http://finance.yahoo.com/news/oxis-international-inc-oxis-technology-124000188.html